Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Sunovion
>
This LAUNCH is a complete FAILURE
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 5149015"]What in the Sam Hill are you talking about? Promote off label?!? Even if that were fostered here (WHICH IT ISN'T), it would not help. Oh my GOD it is impossible to sell this product. Competition is all over our weakness and they are right! Physicians see it too. We are a metabolite of oxcarbazepine people. In fact, all three of our active metabolites are the same active metabolites of oxcarb. </p><p><br /></p><p>Someone on this thread stated that expectations were set way too high. Well, any expectations would be considered too high for a product that should never have been launched. Why did we keep spending money to bring this to market? It's done nothing in Europe and we've been out there for over 5 years. If I were in the home office in Japan I'd have the product managers resignation on my desk by the end of the month. Who misled all of us to come here and promote this pathetic drug. This is not what I signed up for. Interviews were all about telling me how great of a product it will be and the great efficacy and side effect profile. Unfortunately, we are not a novel compound. At least FYCOMPA and Vimpat are unique. We are a retread of a generic at $20 a pill. Wow. Wonder why we are not selling any. It such a mystery. NOT![/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 5149015"]What in the Sam Hill are you talking about? Promote off label?!? Even if that were fostered here (WHICH IT ISN'T), it would not help. Oh my GOD it is impossible to sell this product. Competition is all over our weakness and they are right! Physicians see it too. We are a metabolite of oxcarbazepine people. In fact, all three of our active metabolites are the same active metabolites of oxcarb. Someone on this thread stated that expectations were set way too high. Well, any expectations would be considered too high for a product that should never have been launched. Why did we keep spending money to bring this to market? It's done nothing in Europe and we've been out there for over 5 years. If I were in the home office in Japan I'd have the product managers resignation on my desk by the end of the month. Who misled all of us to come here and promote this pathetic drug. This is not what I signed up for. Interviews were all about telling me how great of a product it will be and the great efficacy and side effect profile. Unfortunately, we are not a novel compound. At least FYCOMPA and Vimpat are unique. We are a retread of a generic at $20 a pill. Wow. Wonder why we are not selling any. It such a mystery. NOT![/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Sunovion
>
This LAUNCH is a complete FAILURE
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Sunovion
>
This LAUNCH is a complete FAILURE
>